These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 24753590

  • 1. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
    Trastoy B, Lomino JV, Pierce BG, Carter LG, Günther S, Giddens JP, Snyder GA, Weiss TM, Weng Z, Wang LX, Sundberg EJ.
    Proc Natl Acad Sci U S A; 2014 May 06; 111(18):6714-9. PubMed ID: 24753590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
    Dixon EV, Claridge JK, Harvey DJ, Baruah K, Yu X, Vesiljevic S, Mattick S, Pritchard LK, Krishna B, Scanlan CN, Schnell JR, Higgins MK, Zitzmann N, Crispin M.
    J Biol Chem; 2014 May 16; 289(20):13876-89. PubMed ID: 24668806
    [Abstract] [Full Text] [Related]

  • 4. Liquid-liquid diffusion crystallization improves the X-ray diffraction of EndoS, an endo-β-N-acetylglucosaminidase from Streptococcus pyogenes with activity on human IgG.
    Trastoy B, Lomino JV, Wang LX, Sundberg EJ.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec 16; 69(Pt 12):1405-10. PubMed ID: 24316841
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of antibody-specific deglycosylation and immune evasion by Streptococcal IgG-specific endoglycosidases.
    Trastoy B, Du JJ, Cifuente JO, Rudolph L, García-Alija M, Klontz EH, Deredge D, Sultana N, Huynh CG, Flowers MW, Li C, Sastre DE, Wang LX, Corzana F, Mallagaray A, Sundberg EJ, Guerin ME.
    Nat Commun; 2023 Mar 27; 14(1):1705. PubMed ID: 36973249
    [Abstract] [Full Text] [Related]

  • 6. Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.
    Trastoy B, Klontz E, Orwenyo J, Marina A, Wang LX, Sundberg EJ, Guerin ME.
    Nat Commun; 2018 May 14; 9(1):1874. PubMed ID: 29760474
    [Abstract] [Full Text] [Related]

  • 7. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
    Allhorn M, Olsén A, Collin M.
    BMC Microbiol; 2008 Jan 08; 8():3. PubMed ID: 18182097
    [Abstract] [Full Text] [Related]

  • 8. Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS.
    Sudol ASL, Butler J, Ivory DP, Tews I, Crispin M.
    Nat Commun; 2022 Dec 17; 13(1):7801. PubMed ID: 36528711
    [Abstract] [Full Text] [Related]

  • 9. Insights into substrate recognition and specificity for IgG by Endoglycosidase S2.
    Aytenfisu AH, Deredge D, Klontz EH, Du J, Sundberg EJ, MacKerell AD.
    PLoS Comput Biol; 2021 Jul 17; 17(7):e1009103. PubMed ID: 34310592
    [Abstract] [Full Text] [Related]

  • 10. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
    Sjögren J, Struwe WB, Cosgrave EF, Rudd PM, Stervander M, Allhorn M, Hollands A, Nizet V, Collin M.
    Biochem J; 2013 Oct 01; 455(1):107-18. PubMed ID: 23865566
    [Abstract] [Full Text] [Related]

  • 11. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.
    Du JJ, Klontz EH, Guerin ME, Trastoy B, Sundberg EJ.
    Glycobiology; 2020 Mar 20; 30(4):268-279. PubMed ID: 31172182
    [Abstract] [Full Text] [Related]

  • 12. Sugar-free antibodies--the bacterial solution to autoimmunity?
    Allhorn M, Collin M.
    Ann N Y Acad Sci; 2009 Sep 20; 1173():664-9. PubMed ID: 19758213
    [Abstract] [Full Text] [Related]

  • 13. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
    Collin M, Olsén A.
    Infect Immun; 2001 Nov 20; 69(11):7187-9. PubMed ID: 11598100
    [Abstract] [Full Text] [Related]

  • 14. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.
    Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsén A.
    Infect Immun; 2002 Dec 20; 70(12):6646-51. PubMed ID: 12438337
    [Abstract] [Full Text] [Related]

  • 15. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
    Collin M, Olsén A.
    EMBO J; 2001 Jun 15; 20(12):3046-55. PubMed ID: 11406581
    [Abstract] [Full Text] [Related]

  • 16. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
    Sjögren J, Cosgrave EF, Allhorn M, Nordgren M, Björk S, Olsson F, Fredriksson S, Collin M.
    Glycobiology; 2015 Oct 15; 25(10):1053-63. PubMed ID: 26156869
    [Abstract] [Full Text] [Related]

  • 17. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W, Giddens J, Fan SQ, Toonstra C, Wang LX.
    J Am Chem Soc; 2012 Jul 25; 134(29):12308-18. PubMed ID: 22747414
    [Abstract] [Full Text] [Related]

  • 18. Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence.
    Sjögren J, Okumura CY, Collin M, Nizet V, Hollands A.
    BMC Microbiol; 2011 May 27; 11():120. PubMed ID: 21619648
    [Abstract] [Full Text] [Related]

  • 19. An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.
    Goodfellow JJ, Baruah K, Yamamoto K, Bonomelli C, Krishna B, Harvey DJ, Crispin M, Scanlan CN, Davis BG.
    J Am Chem Soc; 2012 May 16; 134(19):8030-3. PubMed ID: 22551167
    [Abstract] [Full Text] [Related]

  • 20. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
    Collin M, Shannon O, Björck L.
    Proc Natl Acad Sci U S A; 2008 Mar 18; 105(11):4265-70. PubMed ID: 18332429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.